📰 Cel Sci News
Cel Sci News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cel Sci. Real-time updates on events, politics, business and more.
April 24, 2024
Cutter & CO Brokerage Inc. decreased its stake in CEL-SCI Co. (NYSE:CVM – Free Report) by 17.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 84,711 shares of the company’s stock after selling 18,134 shares during the quarter. Cutter & […]
April 24, 2024
Cutter & CO Brokerage Inc. cut its position in shares of CEL-SCI Co. (NYSE:CVM – Free Report) by 17.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 84,711 shares of the company’s stock after selling 18,134 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in CEL-SCI were worth $230,000 at the […]
December 24, 2023
CEL-SCI (NYSE:CVM – Get Free Report) issued its earnings results on Friday. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02), Yahoo Finance reports. CEL-SCI Price Performance NYSE:CVM opened at $2.75 on Friday. CEL-SCI has a one year low of $1.04 and a one year high […]
October 8, 2023
StockNews.com began coverage on shares of CEL-SCI (NYSE:CVM – Free Report) in a report published on Thursday morning. The firm issued a sell rating on the stock. CEL-SCI Stock Performance NYSE:CVM opened at $1.19 on Thursday. The company has a current ratio of 1.46, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. […]
September 20, 2023
CEL-SCI (NYSE:CVM – Get Free Report) and Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Volatility and Risk CEL-SCI has a beta of […]
August 15, 2023
StockNews.com cut shares of CEL-SCI (NYSE:CVM – Free Report) from a hold rating to a sell rating in a research note issued to investors on Friday. CEL-SCI Trading Up 0.4 % Shares of CVM stock opened at $1.25 on Friday. The company has a current ratio of 1.46, a quick ratio of 1.06 and a […]
August 5, 2023
StockNews.com upgraded shares of CEL-SCI (NYSE:CVM – Free Report) from a sell rating to a hold rating in a report published on Tuesday. CEL-SCI Stock Down 5.1 % CVM stock opened at $1.49 on Tuesday. CEL-SCI has a 52-week low of $1.45 and a 52-week high of $5.42. The company’s 50 day simple moving average […]
July 28, 2023
StockNews.com downgraded shares of CEL-SCI (NYSE:CVM – Free Report) from a hold rating to a sell rating in a research note published on Monday morning. CEL-SCI Price Performance Shares of CVM stock opened at $1.71 on Monday. CEL-SCI has a 1-year low of $1.68 and a 1-year high of $5.42. The company has a current […]
July 8, 2023
StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research report released on Tuesday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Price Performance Shares […]
July 8, 2023
CEL-SCI Co. (NYSEAMERICAN:CVM – Free Report)’s stock price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.39 and traded as low as $2.35. CEL-SCI shares last traded at $2.44, with a volume of 108,333 shares. Analysts Set New Price Targets Separately, StockNews.com […]